BOM:524506 (India)
Â
Shs Dematerialised
₹
786.50
(-1.44%)
Nov 29
Business Description
Coral Laboratories Ltd
ISIN : INE683E01017
Share Class Description:
BOM:524506: Shs DematerialisedCompare
Compare
Traded in other countries / regions
524506.India IPO Date
2001-12-26Description
Coral Laboratories Ltd is engaged in the pharmaceutical business. The company is involved in the formulation of medicines. The company's dosage form includes tablets, capsules, liquid orals, b-lactam, dry syrup, meter dose inhalers, injectables, drops, sprays, special kits, and others. Its geographical segments include Ethiopia, India, and the Rest of the world.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.88 | |||||
| Interest Coverage | 591.31 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.67 | |||||
| Beneish M-Score | -2.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.8 | |||||
| 3-Year EBITDA Growth Rate | 5 | |||||
| 3-Year EPS without NRI Growth Rate | 5.2 | |||||
| 3-Year FCF Growth Rate | -146.8 | |||||
| 3-Year Book Growth Rate | 9.1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.58 | |||||
| 9-Day RSI | 42.41 | |||||
| 14-Day RSI | 42.73 | |||||
| 6-1 Month Momentum % | 56.18 | |||||
| 12-1 Month Momentum % | 98.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.83 | |||||
| Quick Ratio | 6.31 | |||||
| Cash Ratio | 3.69 | |||||
| Days Inventory | 91.12 | |||||
| Days Sales Outstanding | 108.95 | |||||
| Days Payable | 53.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.25 | |||||
| Dividend Payout Ratio | 0.03 | |||||
| Forward Dividend Yield % | 0.25 | |||||
| 5-Year Yield-on-Cost % | 0.25 | |||||
| Shareholder Yield % | 0.25 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.04 | |||||
| Operating Margin % | 21.59 | |||||
| Net Margin % | 21.16 | |||||
| FCF Margin % | -5.91 | |||||
| ROE % | 12.54 | |||||
| ROA % | 10.91 | |||||
| ROIC % | 13.28 | |||||
| ROC (Joel Greenblatt) % | 35.12 | |||||
| ROCE % | 16.37 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.15 | |||||
| PE Ratio without NRI | 12.15 | |||||
| Shiller PE Ratio | 17.58 | |||||
| PEG Ratio | 4.86 | |||||
| PS Ratio | 2.57 | |||||
| PB Ratio | 1.38 | |||||
| Price-to-Tangible-Book | 1.38 | |||||
| EV-to-EBIT | 6.11 | |||||
| EV-to-EBITDA | 5.74 | |||||
| EV-to-Revenue | 1.74 | |||||
| EV-to-FCF | -29.39 | |||||
| Price-to-Projected-FCF | 1.9 | |||||
| Price-to-Median-PS-Value | 1.63 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.84 | |||||
| Price-to-Graham-Number | 0.86 | |||||
| Price-to-Net-Current-Asset-Value | 1.99 | |||||
| Price-to-Net-Cash | 4.45 | |||||
| Earnings Yield (Greenblatt) % | 16.37 | |||||
| FCF Yield % | -2.3 | |||||
| Forward Rate of Return (Yacktman) % | 2.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Coral Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,092.873 | ||
| EPS (TTM) (₹) | 64.73 | ||
| Beta | 1.59 | ||
| Volatility % | 56.16 | ||
| 14-Day RSI | 42.73 | ||
| 14-Day ATR (₹) | 44.372118 | ||
| 20-Day SMA (₹) | 822.4575 | ||
| 12-1 Month Momentum % | 98.62 | ||
| 52-Week Range (₹) | 344.9 - 999 | ||
| Shares Outstanding (Mil) | 3.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Coral Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Coral Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Coral Laboratories Ltd Frequently Asked Questions
What is Coral Laboratories Ltd(BOM:524506)'s stock price today?
The current price of BOM:524506 is ₹786.50. The 52 week high of BOM:524506 is ₹999.00 and 52 week low is ₹344.90.
When is next earnings date of Coral Laboratories Ltd(BOM:524506)?
The next earnings date of Coral Laboratories Ltd(BOM:524506) is .
Does Coral Laboratories Ltd(BOM:524506) pay dividends? If so, how much?
The Dividend Yield %  of Coral Laboratories Ltd(BOM:524506) is 0.25% (As of Today), Highest Dividend Payout Ratio of Coral Laboratories Ltd(BOM:524506) was 0.14. The lowest was 0.03. And the median was 0.07. The  Forward Dividend Yield % of Coral Laboratories Ltd(BOM:524506) is 0.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers